Autori: Rhoten Patricia
| Naslov | Recruitment in a randomized, double-blind, placebo-controlled study to assess siltuximab (CNTO 328), an anti-IL-6 monoclonal antibody, in patients with multicentric Castleman's disease. (Meeting Abstract) |
| Autori | Van Rhee Frits Capra Marcelo Wong Raymond Vermeulen Jessica Safer Karim Todorovic Marija Rhoten Patricia Van de Velde Helgi |
| Info | JOURNAL OF CLINICAL ONCOLOGY, (2012), vol. 30 br. 15, Suppl. S, str. - |
| Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
     |
